Standard BioTools Inc.
US ˙ NasdaqGS ˙ US34385P1084

SecurityLAB / Standard BioTools Inc.
InstitutionAllworth Financial LP
Latest Disclosed Ownership1,481 shares
Latest Disclosed Value $ 1,362
Allworth Financial LP reports 114.33% increase in ownership of LAB / Standard BioTools Inc.

On May 14, 2026 - Allworth Financial LP filed a 13F-HR form disclosing ownership of 1,481 shares of Standard BioTools Inc. (US:LAB) valued at $1,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 691 shares of Standard BioTools Inc.. The current value of the position is $1,688 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F STANDARD BIOTOOLS COM 34385P108 1,481 790 114.33 1 0.0000
2026-02-05 2025-12-31 13F STANDARD BIOTOOLS COM 34385P108 691 -113 -14.05 1 -100.00 0.0000
2025-12-02 2025-09-30 13F STANDARD BIOTOOLS COM 34385P108 804 26 3.34 1 0.0000
2025-08-07 2025-06-30 13F STANDARD BIOTOOLS COM 34385P108 778 -36 -4.42 1 -100.00 0.0000
2025-04-30 2025-03-31 13F STANDARD BIOTOOLS COM 34385P108 814 114 16.29 1 0.00 0.0000
2025-01-30 2024-12-31 13F STANDARD BIOTOOLS COM 34385P108 700 -252 -26.47 1 0.00 0.0000
2024-10-23 2024-09-30 13F STANDARD BIOTOOLS COM 34385P108 952 107 12.66 2 0.00 0.0000
2024-07-24 2024-06-30 13F STANDARD BIOTOOLS COM 34385P108 845 0 0.00 2 -50.00 0.0000
2024-04-25 2024-03-31 13F STANDARD BIOTOOLS COM 34385P108 845 0 0.00 2 100.00 0.0000
2024-01-24 2023-12-31 13F STANDARD BIOTOOLS COM 34385P108 845 0 0.00 2 -50.00 0.0000
2023-10-31 2023-09-30 13F STANDARD BIOTOOLS COM 34385P108 845 145 20.71 2 100.00 0.0000
2023-07-18 2023-06-30 13F STANDARD BIOTOOLS COM 34385P108 700 0 0.00 1 0.00 0.0000
2023-04-18 2023-03-31 13F STANDARD BIOTOOLS COM 34385P108 700 700 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.